Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cytokines as natural adjuvants for vaccines: where are we now?
Rizza P, Ferrantini M, Capone I, Belardelli F. Rizza P, et al. Among authors: capone i. Trends Immunol. 2002 Aug;23(8):381-3. doi: 10.1016/s1471-4906(02)02276-7. Trends Immunol. 2002. PMID: 12133794 No abstract available.
Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.
Di Pucchio T, Pilla L, Capone I, Ferrantini M, Montefiore E, Urbani F, Patuzzo R, Pennacchioli E, Santinami M, Cova A, Sovena G, Arienti F, Lombardo C, Lombardi A, Caporaso P, D'Atri S, Marchetti P, Bonmassar E, Parmiani G, Belardelli F, Rivoltini L. Di Pucchio T, et al. Among authors: capone i. Cancer Res. 2006 May 1;66(9):4943-51. doi: 10.1158/0008-5472.CAN-05-3396. Cancer Res. 2006. PMID: 16651452 Clinical Trial.
International meeting "Immunotherapy of cancer: challenges and needs".
Ferrantini M, Capone I, Marincola FM, Parmiani G, Belardelli F. Ferrantini M, et al. Among authors: capone i. Cancer Immunol Immunother. 2007 Apr;56(4):581-5. doi: 10.1007/s00262-006-0251-6. Epub 2006 Nov 28. Cancer Immunol Immunother. 2007. PMID: 17131119 Free PMC article.
Dendritic cells and cytokines in immune rejection of cancer.
Ferrantini M, Capone I, Belardelli F. Ferrantini M, et al. Among authors: capone i. Cytokine Growth Factor Rev. 2008 Feb;19(1):93-107. doi: 10.1016/j.cytogfr.2007.10.003. Epub 2007 Dec 3. Cytokine Growth Factor Rev. 2008. PMID: 18054517 Review.
Evaluation of the effects of human leukocyte IFN-alpha on the immune response to the HBV vaccine in healthy unvaccinated individuals.
Rizza P, Capone I, Urbani F, Montefiore E, Rapicetta M, Chionne P, Candido A, Tosti ME, Grimaldi M, Palazzini E, Viscomi G, Cursaro C, Margotti M, Scuteri A, Andreone P, Taylor E, Haygreen EA, Tough DF, Borrow P, Selleri M, Castilletti C, Capobianchi M, Belardelli F. Rizza P, et al. Among authors: capone i. Vaccine. 2008 Feb 20;26(8):1038-49. doi: 10.1016/j.vaccine.2007.12.044. Epub 2008 Jan 18. Vaccine. 2008. PMID: 18249478 Clinical Trial.
Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients.
Nisticò P, Capone I, Palermo B, Del Bello D, Ferraresi V, Moschella F, Aricò E, Valentini M, Bracci L, Cognetti F, Ciccarese M, Vercillo G, Roselli M, Fossile E, Tosti ME, Wang E, Marincola F, Imberti L, Catricalà C, Natali PG, Belardelli F, Proietti E. Nisticò P, et al. Among authors: capone i. Int J Cancer. 2009 Jan 1;124(1):130-9. doi: 10.1002/ijc.23886. Int J Cancer. 2009. PMID: 18839429 Free article. Clinical Trial.
Recombinant interferon-alpha2b improves immune response to hepatitis B vaccination in haemodialysis patients: results of a randomised clinical trial.
Miquilena-Colina ME, Lozano-Rodríguez T, García-Pozo L, Sáez A, Rizza P, Capone I, Rapicetta M, Chionne P, Capobianchi M, Selleri M, Castilletti C, Belardelli F, Iacono OL, García-Monzón C. Miquilena-Colina ME, et al. Among authors: capone i. Vaccine. 2009 Sep 18;27(41):5654-60. doi: 10.1016/j.vaccine.2009.07.014. Epub 2009 Jul 25. Vaccine. 2009. PMID: 19635606 Clinical Trial.
65 results